 |
|
| 文 献 | |
|
|
| 1 | Gruentzig AR. Translumination dilatation of coronary artery stenosis. Lancet. 1978; 1; 263. PubMed |
| 2 | Kuntz RE et al. The importance of luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992; 86: 1827-35. PubMed |
| 3 | Topol EJ et al for the CAVEAT study group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993; 329: 221-7. PubMed |
| 4 | Adelman AG et al. A comparison of directional atherｅctomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993; 329: 228-33. PubMed |
| 5 | Baim DS et al for the BOAT investigators. Final results of the balloon vs optimal atherectomy trial (BOAT). Circulation. 1998; 97: 322-31. PubMed |
| 6 | Suzuki T for the ABACAS investigators. Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy; the result of adjunctive balloon angioplasty after coronary atherectomy study (ABACAS). J Am Coll Cardiol. 1999; 34: 1028-35. PubMed |
| 7 | Fischman DL et al for the stent restenosis study investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994; 331: 496-501. PubMed |
| 8 | Serruys PW et al for the BENESTENT study group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994; 331: 489-95. PubMed |
| 9 | de Jaegere P et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J. 1998; 19: 1214-23. PubMed |
| 10 | Colombo A et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 91: 1676-88. PubMed |
| 11 | Schoemig A et al. Randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334; 1084-9. PubMed |
| 12 | Stankovic G et al. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. Am J Cardiol. 2004; 93: 953-8. PubMed |
| 13 | Okura H et al for the REDUCE investigators. Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified lesions: an intravascular ultra sound study. Catheter Cardiovasc Interv. 2002; 57: 429-36. PubMed |
| 14 | Mauri L et al. Cutting balloon andioplasty for the prevention of restenosis： Results of the cutting balloon global randomized trial. Am J Cardiol. 2002; 90: 1079-83. PubMed |
| 15 | Albiero R et al for the RESCUT investigators. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol. 2004; 4: 943-9. PubMed |
| 16 | Suzuki T et al presented at Transcatheter Cardiovascular Therapeutics (TCT) 2002 |
| 17 | Raizner AE et al. Inhibition of restenosis with β-emitting radiotherapy report of the proliferation reduction with vascular energy trial（PREVENT）. Circulation. 2000; 102: 951-8. PubMed |
| 18 | Waksman R et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis; the INHIBIT randomised controlled trial. Lancet. 2002; 359: 551-7. PubMed |
| 19 | Popma J et al. Late clinical and angiographic outcomes after use of 90Sr/ 90Y beta radiation for the treatment of in-stent restenosis: Results from the 90Sr treatment of angiographic restenosis (START) trial. Circulation 2002; 106: 1090-6. PubMed |
| 20 | Kuntz RE presented at the American College of Cardiology (ACC) 2001. |
| 21 | Teirstein PS et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997; 336: 1697-703. PubMed |
| 22 | Waksman R et al for the Washington radiation for in-stent restenosis trial (WRIST) investigators. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 2000; 101: 2165-71. PubMed |
| 23 | Leon MB et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001; 344: 250-6. PubMed |
| 24 | Sousa JE et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. One-year angiographic and intravascular ultrasound follow-up. Circulation. 2001; 104; 2007-11. PubMed |
| 25 | Morice MC et al for the RAVEL study group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346: 1773-80. PubMed |
| 26 | Moses JW et al for the SIRIUS investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315-23. PubMed |
| 27 | Schofer J et al for the E-SIRIUS investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003; 362: 1093-9. PubMed |
| 28 | Schampaert E et al for the C-SIRIUS investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004; 43: 1110-5. PubMed |
| 29 | Moses J presented at ACC 2004 |
| 30 | Guagliumi et al presented at TCT 2004 |
| 31 | TCT http://www.tctmd.com/csportal/appmanager/tctmd/main |
| 32 | Stone GW et al for the TAXUS V investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005; 294: 1215-23. PubMed |
| 33 | Lemos PA et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Circulation. 2004; 109: 190-5. PubMed |
| 34 | TCT http://www.tctmd.com/csportal/appmanager/tctmd/main |
| 35 | Colombo A et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-9. PubMed |
| 36 | Park SJ et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantation. J Am Coll Cardiol 2005; 45: 351-6. PubMed |
| 37 | Lotan C. presented at TCT 2004 |
| 38 | Holmes DR et al. Sirolimus-eluting stent vs vascular brachytherapy for in-stent restenosis within bare-metal stents. The SISR randomized trial. JAMA. 2006; 295: 1264-73. PubMed |
| 39 | Kastrati A et al for the ISAR-DESIRE study investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005; 293: 165-71. PubMed |
| 40 | Ardissino D et al for the SES-SMART investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA. 2004; 292: 2727-34. PubMed |
| 41 | Valgimigli M et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005; 293; 2109-17. PubMed |
| 42 | Sabate M et al for the DIABETES investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005; 112: 2175-83. PubMed |
| 43 | C Macaya presented at European Society of Cardiology （ESC） 2005. |
| 44 | Tanabe K et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003; 107: 559-64. PubMed |
| 45 | Stone GW et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare metal stents. JAMA 2006; 295: 1253-63. PubMed |
| 46 | Colombo A et al for the TAXUS II study group. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003; 108: 788-94. PubMed |
| 47 | Stone GW et al for the TAXUS-IV investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004; 350: 221-31. PubMed |
| 48 | Dawkins KD et al on behalf of the TAXUS VI investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005; 112: 3306-13. PubMed |
| 49 | Spaulding C presented at ACC 2006 |
| 50 | 米国医学図書館運営の臨床試験登録公開サイト http://www.clinicaltrials.gov/show/NCT00114972 （アクセス日 2006年5月2日） |
| 51 | Windecker S et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005; 353: 653-62. PubMed |
| 52 | Dibra A et al for the ISAR-DIABETES study investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005; 353: 663-70. PubMed |
| 53 | Moricce MC et al. Sirolims vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial; a rondomized controlled trial. JAMA 2006; 295: 895-904. PubMed |
| 54 | de Lezo J. et al J Am Coll Cardiol. 2005; 45 (suppl): 75A. |
| 55 | Goy JJ et al. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol. 2005; 45: 308-11. PubMed |
| 56 | Mehilli J et al for the intracoronary drug-eluting stenting to abrogate restenosis in small arteries（ISAR-SMART 3）study investigators. Randomized trial of paclitaxel and sirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006; 27: 260-6. PubMed |
| 57 | RITA trial participants. Coronary angioplasty versus coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial. Lancet. 1993; 341: 573-80. PubMed |
| 58 | Rodrigues A et al. Three-year follow-up of the Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERAC I). J Am Coll Cardiol. 1996; 27: 1178-84. PubMed |
| 59 | Rupprecht HJ et al. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). Eur Heart J. 1996; 17: 1192-8. PubMed |
| 60 | King SB 3rd et al for the emory angioplasty versus surgery trial (EAST). A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994; 331: 1044-50. PubMed |
| 61 | CABRI trial participants. First-year results of CABRI (coronary angioplasty versus bypass revascularisation investigation). Lancet. 1995; 346: 1179-84. PubMed |
| 62 | The bypass angioplasty revascularization investigation (BARI) investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996; 335: 217-25. PubMed |
| 63 | Rodriguez A et al for the ERACI II investigators. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II); 30-day and one-year follow-up results. J Am Coll Cardiol. 2001; 37: 51-8. PubMed |
| 64 | Serruys PW et al for the arterial revascularization therapies study group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001; 344: 1117-24. PubMed |
| 65 | Stables RH for the SoS investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomised controlled trial. Lancet. 2002; 360: 965-70. PubMed |
| 66 | Park SJ et al. presented at TCT 2005. |
| 67 | http://www.clinicaltrials.gov/show/NCT00086450 （アクセス日 2006年5月2日） |
| 68 | McFadden et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004 ; 364; 1519-21. PubMed |
| 69 | Leon MB presented at TCT 2005 |
| 70 | Leon MB presented at TCT 2005 |
| 71 | Gershlick A et al: Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation. 2004; 109: 487-93. PubMed |
〔閉じる〕